JS
Joseph Stringer Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
90
Avg Return
Past Year
Past Year
10%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
78.1%
Neutral
21.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Hold
Reiterated
| – | – | 2 | – |
–
| 20 Oct ‘25 10 hours ago |
|
|
Buy
Maintained
| $35 |
2%
upside
| 7 | +29% |
0
%
| 10 Oct ‘25 10 days ago |
|
|
Buy
Maintained
| $78 |
6%
upside
| 9 | +9.6% |
0
%
| 8 Oct ‘25 12 days ago |
|
|
Buy
Maintained
| $100 |
0%
upside
| 7 | +36% |
0
%
| 24 Sep ‘25 26 days ago |
|
|
Buy
Maintained
| $65 |
33%
upside
| 5 | +10% |
0
%
| 10 Sep ‘25 1 month ago |
|
|
Buy
Maintained
| $478 |
2%
downside
| 8 | +9.7% |
0
%
| 31 Jul ‘25 2 months ago |
|
|
Buy
Upgraded
| $133 |
8%
upside
| 5 | +8.9% |
0
%
| 25 Jul ‘25 2 months ago |
|
|
Buy
Maintained
| $95 |
15%
downside
| 9 | +11% |
0
%
| 9 Jul ‘25 3 months ago |
|
|
Buy
Maintained
| $28 |
111%
upside
| 7 | +18% |
0
%
| 6 Jun ‘25 4 months ago |
|
|
Buy
Reiterated
| $14 |
127%
upside
| 5 | +1.1% |
0
%
| 22 May ‘25 5 months ago |
|
|
Hold
Downgraded
| $12 |
200%
upside
| 6 | -11% |
0
%
| 16 May ‘25 5 months ago |
|
|
Buy
Maintained
| $11 |
243%
upside
| 3 | -3% |
0
%
| 13 May ‘25 5 months ago |
|
|
Buy
Maintained
| $29 |
8%
upside
| 2 | +3.4% |
0
%
| 7 May ‘25 5 months ago |
|
|
Hold
Reiterated
| – | – | 4 | – |
–
| 6 May ‘25 5 months ago |
|
|
Buy
Reiterated
| $90 |
110%
upside
| 5 | -12% |
0
%
| 8 Apr ‘25 6 months ago |
|
|
Hold
Reiterated
| – | – | 9 | – |
–
| 7 Mar ‘25 7 months ago |
|
|
Hold
Downgraded
| $10 |
529%
upside
| 3 | -58% |
0
%
| 4 Mar ‘25 7 months ago |
|